Fostering research excellence
in EU Outermost Regions
Fostering research excellence
La Reunion
Infrastructure
Research centers or research group
CYROI is a public interest group managed by the University Hospital, the
University of Reunion Island and the Northern Inter-Municipal Association
(CINOR). It manages a 4,500 m2 biotechnology technical support platform,
funded by Europe, the Regional Council, the French government, Departmental
Council and CINOR.
CYROI is based in Saint Denis at the Technopole science park, close to Roland
Garros international airport. It has a pharmaceutical unit, academic research
teams and associations working on specific topics (emerging infectious
diseases, metabolic diseases and promotion of biodiversity). It also provides
services to public and private clients and conducts research and innovation
projects with its partners.
The CYROI is divided into three units with combined services :
Research topics focusing on :
Pharmaceutical production
CYROI has secured National Medicine Safety Agency approval as an official
pharmaceutical body. The radio-pharmaceutical production unit produces
radio-pharmaceuticals used in cancer imaging through positron emission
tomography. Fludeoxyglucose (18FDG) is issued daily to the university
hospital’s nuclear medicine department and covers public health needs in
the region of Reunion and Mayotte.
Small animal radio chemistry and imaging
Radio chemistry is used to insert a radionuclide in a study molecule. After
the radio-identification phase, these radioactive molecules are validated
in vitro, before being injected in vivo into small animals, after approval of
the experimentation protocol has been approved by the Ethics Committee.
CYROI has a cutting-edge pre-clinical imaging tool using positron emission
tomography and single-photon emission tomography.
CYROI responds to scientific partnership requests in Reunion,
or internationally, based on suitable research projects. These
projects involve CYROI support teams. Projects are subject to
research and innovation partnership agreements.
The CYROI group (GIP) hosts research teams :
All the resident research teams are on www.cyroi.re :
PIMIT DéTROI ASTRE (CIRAD) MIVEGEC-TIS (IRD) APLAMEDOM
The CYROI Group (GIP) provides public and private services. Its strength lies in its ability to understand customer needs, to employ the means required and to adapt to changes during the project.
The analytical unit can define compounds of interest or carry out physical-chemical analyses to extract, detect, identify and quantify organic molecules in complex matrices, etc.
Activities provided by the BIOR unit include :
bibliographic studies, scientific and technological monitoring, characterisation of extracts (sensorial and physicochemical analyses); phytochemical, spectroscopic and
chromatographic analyses (equipment is available and the methods approved on our platform) for profiling and characterisation of samples (composition and active content);
toxicological analyses to determine cytotoxic effects ;in vitro biological activity tests(cytotoxicity, anti-microbial effects, antioxidant, anti-inflammatory, anti-enzymatic effects) on acellular or cellular models ; microbiological analyses, study of the stability and conservation of cosmetics products (listing and detection of non-specified and pathogenic microorganisms on finished products or on raw materials, test for accelerated ageing, challenge-tests), etc.
The fields of activity for animal research projects conducted
in the animal facility with wide-ranging : trials to test the efficacy or toxicity of medicines and other biological or chemical substances, quality controls on food, pre-clinical and medical research into chronic metabolic diseases (diabetes, atherosclerosis /atherothrombosis, strokes, chronic kidney failure), human medical research into infectious diseases (without using pathogens), research into diagnosing illness using medical imaging.
PLEASE NOTE : the CYROI is a public interest group (GIP) approved by the Ministry of Research, allowing companies requesting services from CYROI can benefit from research tax
credit at a higher rate.
Research topics focusing on :
Pharmaceutical production
CYROI has secured National Medicine Safety Agency approval as an official
pharmaceutical body. The radio-pharmaceutical production unit produces
radio-pharmaceuticals used in cancer imaging through positron emission
tomography. Fludeoxyglucose (18FDG) is issued daily to the university
hospital’s nuclear medicine department and covers public health needs in
the region of Reunion and Mayotte.
Small animal radio chemistry and imaging
Radio chemistry is used to insert a radionuclide in a study molecule. After
the radio-identification phase, these radioactive molecules are validated
in vitro, before being injected in vivo into small animals, after approval of
the experimentation protocol has been approved by the Ethics Committee.
CYROI has a cutting-edge pre-clinical imaging tool using positron emission
tomography and single-photon emission tomography.
CYROI responds to scientific partnership requests in Reunion,
or internationally, based on suitable research projects. These
projects involve CYROI support teams. Projects are subject to
research and innovation partnership agreements.
The CYROI group (GIP) hosts research teams :
All the resident research teams are on www.cyroi.re :
PIMIT DéTROI ASTRE (CIRAD) MIVEGEC-TIS (IRD) APLAMEDOM
The CYROI Group (GIP) provides public and private services. Its strength lies in its ability to understand customer needs, to employ the means required and to adapt to changes during the project.
The analytical unit can define compounds of interest or carry out physical-chemical analyses to extract, detect, identify and quantify organic molecules in complex matrices, etc.
Activities provided by the BIOR unit include :
bibliographic studies, scientific and technological monitoring, characterisation of extracts (sensorial and physicochemical analyses); phytochemical, spectroscopic and
chromatographic analyses (equipment is available and the methods approved on our platform) for profiling and characterisation of samples (composition and active content);
toxicological analyses to determine cytotoxic effects ;in vitro biological activity tests(cytotoxicity, anti-microbial effects, antioxidant, anti-inflammatory, anti-enzymatic effects) on acellular or cellular models ; microbiological analyses, study of the stability and conservation of cosmetics products (listing and detection of non-specified and pathogenic microorganisms on finished products or on raw materials, test for accelerated ageing, challenge-tests), etc.
The fields of activity for animal research projects conducted
in the animal facility with wide-ranging : trials to test the efficacy or toxicity of medicines and other biological or chemical substances, quality controls on food, pre-clinical and medical research into chronic metabolic diseases (diabetes, atherosclerosis /atherothrombosis, strokes, chronic kidney failure), human medical research into infectious diseases (without using pathogens), research into diagnosing illness using medical imaging.
PLEASE NOTE : the CYROI is a public interest group (GIP) approved by the Ministry of Research, allowing companies requesting services from CYROI can benefit from research tax
credit at a higher rate.